AnaptysBio, Inc. (LON:0HFQ)
44.28
-0.78 (-1.73%)
At close: Dec 16, 2025
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of 928.58 million as of December 17, 2025. Its market cap has increased by 55.33% in one year.
Market Cap
928.58M
Enterprise Value
1.00B
Revenue
126.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.28
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from 245.54M to 928.58M, an increase of 278.18%. That is a compound annual growth rate of 16.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 928.58M | 188.55% |
| Dec 31, 2024 | 321.81M | -27.99% |
| Dec 29, 2023 | 446.90M | -38.89% |
| Dec 30, 2022 | 731.27M | 3.07% |
| Dec 31, 2021 | 709.46M | 64.74% |
| Dec 31, 2020 | 430.66M | 29.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.44B |
| HSBC Holdings | 190.63B |
| Shell | 154.77B |
| Unilever | 106.14B |
| Rio Tinto Group | 96.74B |
| British American Tobacco p.l.c. | 93.44B |
| Rolls-Royce Holdings | 91.91B |
| GSK plc | 73.06B |